Penserra Capital Management LLC raised its position in Henry Schein, Inc. (NASDAQ:HSIC) by 18.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,620 shares of the company’s stock after purchasing an additional 726 shares during the quarter. Penserra Capital Management LLC’s holdings in Henry Schein were worth $322,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of HSIC. Alecta Pensionsforsakring Omsesidigt raised its position in Henry Schein by 112.0% in the third quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock valued at $435,693,000 after purchasing an additional 2,806,990 shares during the last quarter. Mackenzie Financial Corp raised its position in Henry Schein by 106.0% in the third quarter. Mackenzie Financial Corp now owns 3,938,233 shares of the company’s stock valued at $322,896,000 after purchasing an additional 2,026,867 shares during the last quarter. Janus Henderson Group PLC raised its position in Henry Schein by 92.1% in the third quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock valued at $230,777,000 after purchasing an additional 1,349,333 shares during the last quarter. Atlanta Capital Management Co. L L C raised its position in Henry Schein by 99.4% in the third quarter. Atlanta Capital Management Co. L L C now owns 2,493,054 shares of the company’s stock valued at $204,405,000 after purchasing an additional 1,242,849 shares during the last quarter. Finally, Neuberger Berman Group LLC raised its position in Henry Schein by 95.9% in the third quarter. Neuberger Berman Group LLC now owns 2,475,058 shares of the company’s stock valued at $202,930,000 after purchasing an additional 1,211,743 shares during the last quarter. Hedge funds and other institutional investors own 91.15% of the company’s stock.

In other news, Director Barry J. Alperin sold 5,796 shares of the firm’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the transaction, the director now directly owns 48,172 shares in the company, valued at $3,408,650.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.19% of the stock is owned by company insiders.

Henry Schein, Inc. (NASDAQ HSIC) opened at $68.43 on Thursday. Henry Schein, Inc. has a 1 year low of $63.01 and a 1 year high of $93.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. The stock has a market capitalization of $10,577.16, a PE ratio of 18.90, a PEG ratio of 1.73 and a beta of 1.00.

Several equities analysts have commented on the company. Leerink Swann reiterated a “market perform” rating and issued a $77.00 target price (down from $87.50) on shares of Henry Schein in a research report on Tuesday, November 7th. Stephens assumed coverage on Henry Schein in a research report on Tuesday, November 28th. They issued an “equal weight” rating and a $76.00 target price for the company. Jefferies Group reiterated a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a research report on Friday, October 20th. Robert W. Baird set a $95.00 target price on Henry Schein and gave the company a “buy” rating in a research report on Thursday, October 19th. Finally, TheStreet downgraded Henry Schein from a “b” rating to a “c+” rating in a research report on Monday, November 6th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and eight have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $84.23.

ILLEGAL ACTIVITY WARNING: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this news story can be read at https://www.thecerbatgem.com/2018/02/15/penserra-capital-management-llc-boosts-holdings-in-henry-schein-inc-hsic.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.